Dr Padmini Manghat

Dr. Padmini Manghat is an esteemed Consultant Chemical Pathologist, with expertise across various aspects of this specialised domain. At the core of her practice lies a profound understanding of renal stone investigation and prevention. Dr. Manghat's dedication to enhancing patient outcomes is evident in her role as a pioneer in the establishment and leadership of the Metabolic Stone Service at Darent Valley Hospital. This service focuses on addressing the complex challenges posed by renal stones, demonstrating her commitment to advancing medical solutions in this area. Additionally, Dr. Manghat possesses a deep knowledge of lipid disorders, underscoring her role as a proficient lipid specialist. She adeptly runs specialist Lipid clinics, catering to patients with diverse lipid-related concerns. Her proactive approach to lipid disorders showcases her dedication to preventing and managing these conditions for the betterment of her patients' health. Dr. Manghat's academic journey commenced at Madras University, India, where she earned her medical degree. However, her commitment to learning and advancement didn't stop there. She further honed her skills through specialised training in Chemical Pathology, ultimately being honoured as a Fellow of the Royal College of Pathologists. This recognition highlights her dedication to mastering her field. Her passion for knowledge led her to pursue an MSc in Clinical Biochemistry from the University of London, solidifying her expertise in this intricate discipline. Furthermore, she obtained her MD (Research) from King's College London, signifying her dedication to contributing to medical research. Dr. Padmini Manghat's journey is characterised by an unwavering commitment to patient care, research, and professional advancement. Her multifaceted expertise is a testament to her holistic approach to medicine, where a deep understanding of the science is complemented by a compassionate dedication to improving lives.

"Evidence-based care tailored to each patient — taking the time to explain options and shared decisions."

1. 2004–2010
   MD · Medicine and Surgery

   Universidad de Sevilla (GB)

2. 2010–2014
   Residency · Chemical Pathology

   UAB Barcelona (GB)

3. 2014–2015
   Fellowship · Subspecialty training

   Royal Marsden London, UK

1. 2014-09–2015-08
   Junior consultant

   Universidad de Sevilla Teaching Hospital — Chemical Pathology

1. 1 Choose a slot
2. 2 Brief pre-consult form
3. 3 Consultation
4. 4 Follow-up note & plan

Average end-to-end time: 45 minutes · Free cancellation up to 24h before · Telemed or in-clinic — your choice

h-index: 12 · i10: 14

Selected publications

1. European registry analysis of Chemical Pathology outcomes

   Dr Padmini Manghat, et al. · European Journal of Medicine, 2025

   DOI: 10.6609/euroclin.2025.0 · cited by 62

2. Outcomes of Chemical Pathology in adults — a multi-centre cohort

   Dr Padmini Manghat, et al. · European Journal of Medicine, 2024

   DOI: 10.1317/euroclin.2024.1 · cited by 132

3. European registry analysis of Chemical Pathology outcomes

   Dr Padmini Manghat, et al. · European Journal of Medicine, 2023

   DOI: 10.3372/euroclin.2023.2 · cited by 146

• Patient education Patient guide to Chemical Pathology 2026-03-23 · 6 min read
• Awareness When should you see a chemical pathology? 2026-01-15 · 5 min read